At the Parliament’s Public Health Committee (SANT) committee meeting Health Commissioner Olivér Várhelyi defended the Commission’s plan to simplify the regulatory framework for medical devices (MDR) and in vitro diagnostic medical devices (IVDR), arguing that Europe must cut red tape without weakening patient safety.
The discussion focused on the Commission’s proposal of 16 December 2025 to amend the rules as part of a broader effort to make the EU health system more innovative, competitive and resilient…
